Sangal Papers (BSE 516096)₹195.00+2.79%Paper & Paper Products
In the Mar 2026 quarter (standalone), Sangal Papers reported sales of ₹36.70 Cr, down 21.6% from Mar 2025, and net profit of ₹0.91 Cr, up 116.7% year on year. For the year to Mar 2026, sales were ₹179 Cr and net profit ₹1.99 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 49.56 | 46.51 | 45.50 | 48.67 | 42.60 | 51.17 | 39.62 | 46.80 | 47.52 | 48.30 | 46.69 | 36.70 |
| Expenses | 47.30 | 46.30 | 43.00 | 46.65 | 40.67 | 47.78 | 38.50 | 45.21 | 45.50 | 47.12 | 45.28 | 34.50 |
| Operating Profit | 2.17 | 0.18 | 2.46 | 1.95 | 1.90 | 3.33 | 1.10 | 1.52 | 1.99 | 1.16 | 1.37 | 2.19 |
| OPM % | 4.4% | 0.4% | 5.4% | 4.0% | 4.4% | 6.5% | 2.8% | 3.2% | 4.2% | 2.4% | 2.9% | 5.9% |
| Other Income | 0.16 | 0.21 | 0.15 | 0.46 | 0.14 | 0.21 | 0.11 | 0.20 | 0.14 | 0.31 | 0.14 | 0.24 |
| Interest | 0.61 | 0.64 | 0.66 | 0.67 | 0.63 | 0.66 | 0.68 | 0.60 | 0.57 | 0.57 | 0.55 | 0.55 |
| Depreciation | 0.45 | 0.45 | 0.45 | 0.40 | 0.49 | 0.52 | 0.45 | 0.50 | 0.49 | 0.50 | 0.50 | 0.56 |
| Profit before tax | 1.28 | −0.69 | 1.53 | 1.37 | 0.93 | 2.37 | 0.09 | 0.65 | 1.10 | 0.43 | 0.49 | 1.33 |
| Tax % | 28.3% | −33.9% | 24.3% | 36.7% | 28.2% | 34.3% | −112.6% | 32.8% | 26.5% | 26.2% | 27.0% | 31.0% |
| Net Profit | 0.90 | −0.44 | 1.14 | 0.85 | 0.66 | 1.55 | 0.16 | 0.42 | 0.79 | 0.29 | 0.34 | 0.91 |
| EPS (Rs) | 6.97 | −3.45 | 8.82 | 6.60 | 5.14 | 11.94 | 1.31 | 3.30 | 6.13 | 2.30 | 2.69 | 7.05 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 94.01 | 104 | 120 | 148 | 125 | 106 | 155 | 226 | 190 | 180 | 179 | 179 |
| Expenses | 87.84 | 98.78 | 114 | 139 | 121 | 102 | 150 | 219 | 184 | 172 | 173 | 172 |
| Operating Profit | 6.02 | 5.02 | 6.02 | 9.04 | 5.02 | 3.01 | 5.02 | 7.02 | 7.03 | 8.03 | 7.02 | 6.71 |
| OPM % | 6.0% | 5.0% | 4.7% | 6.0% | 3.6% | 3.1% | 2.9% | 2.9% | 3.6% | 4.5% | 3.7% | 3.7% |
| Other Income | 0.00 | 0.00 | 1.01 | 1.01 | 0.99 | 0.00 | 0.99 | 1.99 | 0.99 | 0.00 | 1.01 | 0.83 |
| Interest | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 3.01 | 3.01 | 2.01 | 2.24 |
| Depreciation | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.05 |
| Profit before tax | 2.01 | 3.01 | 4.02 | 7.03 | 2.01 | 1.01 | 2.01 | 5.02 | 3.01 | 4.02 | 3.01 | 3.35 |
| Tax % | 33.0% | 34.9% | 28.0% | 15.9% | 5.0% | 13.9% | 21.9% | 29.0% | 28.9% | 30.0% | 29.0% | — |
| Exceptional items | −0.09 | −0.02 | 0.00 | −0.12 | 0.06 | 0.00 | −0.02 | 0.02 | 0.00 | −0.21 | 0.00 | — |
| Net Profit | 1.99 | 1.99 | 2.99 | 5.98 | 1.99 | 0.99 | 1.99 | 2.99 | 1.99 | 2.99 | 1.99 | 2.33 |
| EPS (Rs) | 12.73 | 13.10 | 19.92 | 47.07 | 13.79 | 4.98 | 12.56 | 26.00 | 18.94 | 21.68 | 18.15 | 18.17 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 0.99 |
| Reserves | 18.01 | 19.99 | 20.99 | 24.02 | 29.98 | 31.98 | 33.01 | 34.01 | 38.02 | 39.97 | 42.99 | 45.01 |
| Borrowings | 23.94 | 21.93 | 17.95 | 19.94 | 17.94 | 19.95 | 18.94 | 18.94 | 24.93 | 25.93 | 26.94 | 30.91 |
| Other Liabilities | 15.01 | 14.07 | 12.05 | 18.00 | 19.00 | 15.07 | 17.99 | 18.99 | 25.97 | 22.11 | 21.08 | 21.07 |
| Total Liabilities | 57.97 | 57.00 | 53.00 | 62.97 | 67.93 | 69.01 | 70.95 | 73.95 | 89.93 | 90.02 | 92.02 | 98.98 |
| Fixed Assets | 19.99 | 21.01 | 21.01 | 24.99 | 27.99 | 30.03 | 32.02 | 29.99 | 35.98 | 35.03 | 40.03 | 49.04 |
| CWIP | 0.00 | 0.00 | 2.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.01 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 37.98 | 34.99 | 30.98 | 37.98 | 39.94 | 38.98 | 38.93 | 43.96 | 53.95 | 51.98 | 52.99 | 49.94 |
| Inventories | 16.00 | 13.65 | 9.86 | 14.11 | 15.79 | 13.52 | 13.40 | 16.60 | 22.32 | 22.93 | 23.01 | 22.53 |
| Trade receivables | 19.60 | 20.18 | 18.25 | 21.85 | 22.34 | 22.78 | 24.49 | 24.65 | 28.61 | 24.90 | 26.99 | 23.97 |
| Cash & equivalents | 0.60 | 0.69 | 1.18 | 0.31 | 0.29 | 0.27 | 0.24 | 0.15 | 1.07 | 1.43 | 0.96 | 2.12 |
| Total Assets | 57.97 | 57.00 | 53.00 | 62.97 | 67.93 | 69.01 | 70.95 | 73.95 | 89.93 | 90.02 | 92.02 | 98.98 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 0.99 | 3.99 | 8.97 | 1.99 | 7.97 | 2.99 | 6.98 | 0.99 | 3.99 | 3.99 | 5.98 | 10.96 |
| Cash from investing activity | −3.01 | −2.01 | −2.01 | 0.00 | −5.02 | −2.01 | −3.01 | 0.00 | −8.03 | −3.01 | −4.01 | −12.04 |
| Cash from financing activity | 1.01 | −2.01 | −6.01 | 0.00 | −3.01 | 0.00 | −3.01 | −1.01 | 4.01 | −1.01 | −2.01 | 2.01 |
| Net cash flow | −2.01 | 0.00 | 0.00 | 2.01 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | 0.00 | 1.01 |
| Capex | 3.56 | 1.94 | 2.53 | 0.00 | 5.08 | 2.58 | 3.48 | 1.01 | 8.34 | 3.01 | 4.44 | 12.11 |
| Free cash flow | −3.01 | 1.99 | 6.99 | 2.01 | 2.99 | 0.00 | 2.99 | 0.00 | −3.99 | 0.99 | 0.99 | −0.99 |
| CFO / OP % | 24.1% | 82.1% | 181.1% | 57.1% | 102.1% | 67.1% | 204.1% | 34.1% | 80.1% | 75.1% | 80.1% | 164.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 77 | 78 | 64 | 66 | 55 | 66 | 84 | 58 | 46 | 48 | 55 | 49 |
| Inventory days | 111 | 86 | 56 | 74 | 69 | 72 | 86 | 66 | 58 | 78 | 84 | 52 |
| Days payable | 71 | 54 | 30 | 57 | 54 | 47 | 77 | 51 | 47 | 46 | 44 | 25 |
| Cash conversion cycle | 115 | 108 | 88 | 82 | 68 | 90 | 92 | 71 | 56 | 78 | 92 | 75 |
| Working capital days | 37 | 36 | 34 | 30 | 34 | 38 | 46 | 39 | 26 | 32 | 39 | 30 |
| ROCE % | 12.1% | 12.0% | 11.0% | 12.1% | 20.1% | 8.1% | 5.0% | 7.0% | 12.0% | 9.0% | 10.0% | 7.0% |
For the Mar 2026 quarter, Sangal Papers reported sales of ₹36.70 Cr, down 21.6% year on year and net profit of ₹0.91 Cr, up 116.7% year on year. The operating margin was 5.9%.
Sangal Papers' sales for the year to Mar 2026 were ₹179 Cr; over the last twelve months they were ₹179 Cr.
Net profit for the year to Mar 2026 was ₹1.99 Cr, and ₹2.33 Cr over the last twelve months. Earnings per share over the same trailing period were ₹18.17.
Sangal Papers reported borrowings of ₹30.91 Cr at Mar 2026, against cash and equivalents of ₹2.12 Cr.
Cash from operations was ₹10.96 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹0.99 Cr.